NCT00038571 2018-10-31
Proteasome Inhibitor PS-341 Relapsed or Refractory B Cell Lymphomas Previously Treated With Chemotherapy
M.D. Anderson Cancer Center
Phase 2 Completed
Clinical Trials
7 trialsNCT00413959 2018-09-19
VRCD
Oncology Specialists, S.C.
Phase 2 Terminated
NCT00169468 2018-08-23
Association of Velcade to R-CHOP in the Treatment of B Cell Lymphoma
Lymphoma Study Association
Phase 2 Completed
NCT00837174 2017-09-19
COMBOSTAT
The Methodist Hospital Research Institute
Phase 2 Withdrawn
NCT00379574 2013-03-15
Bortezomib Plus CHOP Every 2 Weeks for Advanced Stage DLBCL
Asan Medical Center
Phase 1/2 Completed
NCT01300793 2012-09-26
V-RICE
University of California, San Francisco
Phase 1 Terminated
NCT00515138 2012-04-12
A Pilot Study of Standard-Dose Rituximab, Ifosfamide, Carboplatin and Etoposide (RICE) Plus Bortezomib (Velcade) in a Dose-Escalating Fashion for Patients With Relapsed or Primary Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma Who Are Candidates for Autologous Stem Cell Transplant
University of California, San Francisco
Phase EARLY_PHASE1 Terminated